Cameco
CCJ
89.07
-3.95
-4.25%
Cameco
US · CCJ
#575 by market cap
Listed 1970
89.07
-3.95
-4.25%
Live - 5344 symbols - heartbeat 273s ago
· 2026-10-08 07:29
Pre-market
87.82
-1.41%
After-hours
89.40
+0.37%
Overnight
88.31
-0.85%
- Market cap
- 38.79B
- P/E (TTM)i
- 156.81
- P/Bi
- 7.75
- EPSi
- 0.95
- Div yieldi
- 0.19%
- 52W posi
- 20%
Reader sentiment
Are you bullish or bearish on CCJ?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 9 analysts
Buy
Avg price target
125.21 +40.6%
Price target rangecurrent 89.07
Low97.00
Avg125.21
High138.00
Buy 89%
Hold 11%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-25 | BofA Securities | -- | BUY | 133.41 |
| 2026-09-24 | RBC Capital | -- | BUY | 129.20 |
| 2026-09-23 | TD Cowen | -- | BUY | 133.41 |
| 2026-09-03 | Jefferies | -- | BUY | 138.00 |
| 2026-08-12 | Truist Financial | -- | BUY | 130.00 |
| 2026-08-06 | BofA Securities | -- | BUY | 133.00 |
| 2026-08-04 | Scotiabank | -- | BUY | 122.88 |
| 2026-08-04 | Stifel | -- | BUY | 126.39 |
| 2026-08-04 | Barclays | -- | HOLD | 97.00 |
| 2026-08-03 | Truist Financial | -- | BUY | -- |
| 2026-07-31 | RBC Capital | -- | BUY | 124.03 |
| 2026-07-27 | UBS | -- | BUY | 116.56 |
| 2026-07-16 | Barclays | -- | HOLD | 104.00 |
| 2026-07-15 | Barclays | -- | HOLD | 104.63 |
| 2026-07-14 | Truist Financial | -- | BUY | 129.00 |
| 2026-07-13 | Truist Financial | -- | BUY | 129.00 |
| 2026-07-09 | BofA Securities | -- | BUY | 140.00 |
| 2026-07-01 | Goldman Sachs | -- | BUY | 133.00 |
| 2026-06-29 | RBC Capital | -- | BUY | 124.72 |
| 2026-06-23 | Goldman Sachs | -- | BUY | 133.00 |
| 2026-06-18 | UBS | -- | HOLD | 117.73 |
| 2026-06-15 | BofA Securities | -- | BUY | -- |
| 2026-06-02 | Stifel | -- | BUY | 128.17 |
| 2026-05-29 | CIBC | -- | BUY | 144.35 |
| 2026-05-21 | Barclays | -- | HOLD | 149.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
B
Momentum strategy signal
Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 1 upgrade vs 0 downgrades among tracked analyst rating changes.
- Most recent: UBS moved from Hold to Buy on 2026-07-27.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-07-27 | UBS | HOLD → BUY | 116.56 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-07-31 | -- | ±6.81% | -2.10% (in line) |
| 2026/Q1 | 2026-05-05 | -- | ±6.99% | -3.21% (in line) |
| 2025/Q4 | 2026-02-13 | -- | ±7.83% | -3.00% (in line) |
| 2025/Q3 | 2025-11-05 | -- | ±6.60% | -1.76% (in line) |
| 2025/Q2 | 2025-07-31 | -- | ±5.67% | -3.63% (in line) |
| 2025/Q1 | 2025-05-01 | -- | ±6.23% | +0.80% (in line) |
| 2024/Q4 | 2025-02-20 | -- | ±6.66% | -0.02% (in line) |
| 2024/Q3 | 2024-11-07 | -- | ±6.81% | +4.63% (in line) |
| 2024/Q2 | 2024-07-31 | -- | ±6.66% | +2.73% (in line) |
| 2024/Q1 | 2024-04-30 | -- | ±7.66% | -7.67% (beat) |
| 2023/Q4 | 2024-02-08 | -- | ±6.36% | -6.93% (beat) |
| 2023/Q3 | 2023-10-31 | -- | ±7.32% | +8.06% (beat) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:29:07 · For reference only, not investment advice and not tailored to your situation.